Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell Therapy for the Treatment of Type 1 DiabetesBusiness Wire • 03/09/23
Vertex Pharmaceuticals Incorporated (VRTX) 43rd Annual Cowen Healthcare Conference TranscriptSeeking Alpha • 03/08/23
Nasdaq Bear Market: 5 Superb Growth Stocks You'll Regret Not Buying on the DipThe Motley Fool • 02/25/23
This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.The Motley Fool • 02/11/23